Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease
Wenxin Wang(Hunan Normal University), Xiaohui Song(Sweet Potato Research Institute), Yan‐Xiao Ji(Wuhan University), Juan Yang(Chengdu Women's and Children's Central Hospital), Manli Hu(Wuhan University), Xuewei Huang(Central South University), Juan‐Juan Qin(Tianjin University of Finance and Economics), Jingjing Cai(Anhui Institute of Architectural Research and Design), Zhi‐Gang She(Wuhan University), Hailong Yang(Gannan Medical University), Ye-Mao Liu(Wuhan University), Haomiao Li(Wuhan University), Peng Zhang(Shaoxing People's Hospital), Xiaojing Zhang(Liaoning Cancer Hospital & Institute), Hongliang Li(Jiangnan University), Xingyuan Zhang(Wuhan University), Hui Liu(Guangxi University), Ze Chen(Tianjin Medical University General Hospital), Lihua Zhu(Jiangxi University of Science and Technology), Feng Zhou(Wuhan University), Yan-Ci Zhao(Wuhan University), Fang Lei(Wuhan University), Weifang Liu(Wuhan University)
Cited by 223
Related Papers
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
A high performance sulfur-doped disordered carbon anode for sodium ion batteries
|Energy & Environmental Science|2015|636
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
Ultrahigh Phosphorus Doping of Carbon for High‐Rate Sodium Ion Batteries Anode
|Advanced Energy Materials|2021|248